![Mark R. Alfenito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark R. Alfenito
Amministratore Delegato presso
Engen Bio LLC
Profilo
Mark R.
Alfenito is currently the President, Chief Executive Officer & Director at Engen Bio LLC and the Chief Executive & Financial Officer at EnGen Bio, Inc. He previously worked as an Associate Director-Corporate Development at Nuvelo, Inc. and as a Vice President-Corporate Development at Dyax Corp.
Alfenito received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Cornell University.
Posizioni attive di Mark R. Alfenito
| Società | Posizione | Inizio |
|---|---|---|
Engen Bio LLC
 Engen Bio LLC Pharmaceuticals: MajorHealth Technology Develops biological drugs and vaccines | Amministratore Delegato | - |
EnGen Bio, Inc.
 EnGen Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and manufacture of biologics including therapeutic proteins, vaccines and monoclonal antibodies | Amministratore Delegato | - |
Precedenti posizioni note di Mark R. Alfenito
| Società | Posizione | Fine |
|---|---|---|
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
Formazione di Mark R. Alfenito
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EnGen Bio, Inc.
EnGen Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and manufacture of biologics including therapeutic proteins, vaccines and monoclonal antibodies | Health Technology |
Engen Bio LLC
Engen Bio LLC Pharmaceuticals: MajorHealth Technology Develops biological drugs and vaccines | Health Technology |
